A major goal of the Fralin Biomedical Research Institute on the Virginia Tech Carilion campus in Roanoke is to turn that research into viable commercial spinoffs that can help treat people. An FBRI offspring is working on a peptide – that’s an amino acid chain – to treat brain and breast cancer:
